Table 1:
Clinical characteristics of the study cohort (n = 36).
| Variable | N (% or IQR) |
|---|---|
| Age (years) | 54 (48–60) |
| Female | 24 (67%) |
| White | 29 (81%) |
| Black | 4(11%) |
| Hispanic | 3 (9%) |
| Diabetes mellitus | 23 (64%) |
| Hyperlipidemia | 28 (78%) |
| Hypertension | 31 (86%) |
| Obesity | 29 (81%) |
| Steatosis grade | |
| 1 | 12 (33%) |
| 2 | 16(44%) |
| 3 | 8 (22%) |
| Lobular Inflammation grade | |
| 0 | 3 (8%) |
| 1 | 24 (67%) |
| 2 | 9 (25%) |
| 3 | 0 |
| Cytological Ballooning | |
| None | 15 (42%) |
| Few | 14 (39%) |
| Many | 7(19%) |
| Fibrosis stage | |
| 0 | 7(19%) |
| 1 | 14 (39%) |
| 2 | 4(11%) |
| 3 | 11 (31%) |
| 4 | 0 |
| Nonalcoholic Steatohepatitis | 23 (64%) |
Hypertension/Hyperlipidemia defined as medical record diagnosis of, hypertension/ hyperlipidemia and/or current use of anti-hypertensive/lipid-lowering pharmacologic therapies. Obesity defined as body mass, index ≥30.0 kg/m2.